Jeito Capital co-leads a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating central nervous system disorders

Jeito Capital co-leads a EUR 104 million financing in Noema Pharma, a clinical-stage biopharma company targeting debilitating

Related Keywords

United States ,Paris ,France General ,France ,Switzerland ,French ,Dennis Riedl ,Assia Mouhout ,Noema Pharma ,Jeito Capitaladded ,Jeito Capitalaims ,Rachel Mears ,Marion Bougeard ,Linkedin ,Twitter ,Noema Pharma The Company ,Jeito Capital ,Sofinnova Partners ,Polaris Partners ,Gilde Healthcare ,Tuberous Sclerosis Complex ,Trigeminal Neuralgia ,Childhood Onset Fluency ,Tourette Syndrome ,Atypical Depression ,Binge Eating ,Europe As Jeito Capital ,Chief Executive Officer ,Private Equity ,Biomed Partners ,Strategic Communications Mary Jane Elliott ,Davide Salvi ,Jeito ,Capital ,Heads ,Billion ,Financing ,Dmoema ,Dharma ,Linical ,Stage ,Iopharma ,Company ,Targeting ,Debilitating ,Central ,Nervous ,System ,Disorders ,